Replies to post #26830 on The Rising Influence of Rising Affluence

[DewDiligence]

ZBH makes small acquisition in tissue healing:

https://finance.yahoo.com/news/zimmer-biomet-acquire-embody-inc-120000718.html

Zimmer Biomet Holdings, Inc., a global medical technology leader, today announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for $155 million at closing and up to an additional $120 million subject to achieving future regulatory and commercial milestones over a three year period. The acquisition is expected to be accretive to overall revenue growth and slightly dilutive to adjusted earnings per share in 2023.

Although this deal is on the small side, it’s significant, IMO, in that ZBH finally feels that its COVID-related issues are behind it.

[DewDiligence]

(ZBH/SYK/JNJ/etc)—“Smart” orthopedic implants track_patient_progress:

https://www.wsj.com/articles/a-knee-replacement-that-talks-to-your-doctor-its-just-the-beginning-2f9940b1

Already, a “smart knee” from medical-device maker Zimmer Biomet Holdings Inc., introduced in 2021, comes with built-in sensors…that can wirelessly transmit a slew of data about how the replacement knee is working.

The details about your gait are sent daily to your orthopedic doctor, who can track your step counts, range of motion and other metrics in the months and years after surgery. Doctors tracking the information can reassure patients who are hitting recovery milestones. Or, if the performance measures fall short, a doctor may intervene to avoid having a patient stuck with an underperforming artificial knee, such as ordering a change in the patient’s physical-therapy regimen.

That’s just the beginning, say doctors and medical-device engineers. They predict sensors will be added to artificial hips, shoulders, and spinal implants. And they envision uses beyond orthopedics…